Sandoz gmbh

What We Do - Sandoz
Trends
Sandoz is a global leader in generic pharmaceuticals and biosimilars, with a mission to discover new ways to improve and extend people's lives. Learn more about our products, our quality standards, our innovation and sustainability efforts, and our...
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name...
Sandoz is a division of the Novartis Group and a global leader in generic pharmaceuticals and biosimilars. The division was established in 2003, when Novartis united all of its generics businesses under the name Sandoz - a single global brand with a...
At Sandoz, we are committed to making access happen for patients around the world. Our purpose and ambition is to shape the future of medicine by providing high-quality generic and biosimilar medicines at affordable prices. Find out more about our...
Sandoz | 911,776 followers on LinkedIn. Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to ...
Sandoz Inc (Sandoz), a subsidiary of Sandoz Group AG, is a generic pharmaceutical company which develops, manufactures and distributes and sells a range of prescription medicines and protein and biosimilars worldwide. The company also provides...
Contact Email datenschutz@novartis.com. Phone Number +49 8024 908 0. Sandoz is a pharmaceutical company that develops, supplies, and markets pharmaceuticals, prescription drugs, biosimilars, generic antibiotics, dermatology, and transplantation...
Novartis adds 50 mln euros to European antibiotics investment budget. November 7, 2022. The latest international Sandoz GmbH news and views from Reuters - one of the world's largest news agencies.
See more